Results
|
|
921.
|
|
|
|
922.
|
|
|
|
923.
|
|
|
|
924.
|
|
|
|
925.
|
Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma. [electronic resource] by
- Gibney, Geoffrey T
- Hamid, Omid
- Lutzky, Jose
- Olszanski, Anthony J
- Mitchell, Tara C
- Gajewski, Thomas F
- Chmielowski, Bartosz
- Hanks, Brent A
- Zhao, Yufan
- Newton, Robert C
- Maleski, Janet
- Leopold, Lance
- Weber, Jeffrey S
Producer: 20200616
In:
Journal for immunotherapy of cancer vol. 7
Availability: No items available.
|
|
|
926.
|
Combination therapy of ipilimumab and nivolumab induced thyroid storm in a patient with Hashimoto's disease and diabetes mellitus: a case report. [electronic resource] by
- Yonezaki, Kazuko
- Kobayashi, Toshihiro
- Imachi, Hitomi
- Yoshimoto, Takuo
- Kikuchi, Fumi
- Fukunaga, Kensaku
- Sato, Seisuke
- Ibata, Tomohiro
- Yamaji, Nao
- Lyu, Jingya
- Dong, Tao
- Murao, Koji
Producer: 20190226
In:
Journal of medical case reports vol. 12
Availability: No items available.
|
|
|
927.
|
|
|
|
928.
|
Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab is associated with a profound long-lasting depletion of Foxp3+ regulatory T cells: a mechanistic explanation for ipilimumab-induced severe enterocolitis? [electronic resource] by
- Nancey, S
- Boschetti, G
- Cotte, E
- Ruel, K
- Almeras, T
- Chauvenet, M
- Stroeymeyt, K
- Moussata, D
- Kaiserlian, D
- Flourié, B
Producer: 20121220
In:
Inflammatory bowel diseases vol. 18
Availability: No items available.
|
|
|
929.
|
Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment. [electronic resource] by
- Revicki, Dennis A
- van den Eertwegh, Alfons J M
- Lorigan, Paul
- Lebbe, Celeste
- Linette, Gerald
- Ottensmeier, Christian H
- Safikhani, Shima
- Messina, Marianne
- Hoos, Axel
- Wagner, Samuel
- Kotapati, Srividya
Producer: 20121127
In:
Health and quality of life outcomes vol. 10
Availability: No items available.
|
|
|
930.
|
Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes. [electronic resource] by
- Kitano, Shigehisa
- Postow, Michael A
- Ziegler, Carly G K
- Kuk, Deborah
- Panageas, Katherine S
- Cortez, Czrina
- Rasalan, Teresa
- Adamow, Mathew
- Yuan, Jianda
- Wong, Philip
- Altan-Bonnet, Gregoire
- Wolchok, Jedd D
- Lesokhin, Alexander M
Producer: 20150330
In:
Cancer immunology research vol. 2
Availability: No items available.
|
|
|
931.
|
|
|
|
932.
|
|
|
|
933.
|
|
|
|
934.
|
|
|
|
935.
|
|
|
|
936.
|
|
|
|
937.
|
Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma. [electronic resource] by
- Rosner, Samuel
- Kwong, Erica
- Shoushtari, Alexander N
- Friedman, Claire F
- Betof, Allison S
- Brady, Mary Sue
- Coit, Daniel G
- Callahan, Margaret K
- Wolchok, Jedd D
- Chapman, Paul B
- Panageas, Katherine S
- Postow, Michael A
Producer: 20190705
In:
Cancer medicine vol. 7
Availability: No items available.
|
|
|
938.
|
Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis. [electronic resource] by
- Xing, Puyuan
- Zhang, Fan
- Wang, Guoqiang
- Xu, Yu
- Li, Chengcheng
- Wang, Shouzheng
- Guo, Yiying
- Cai, Shangli
- Wang, Yan
- Li, Junling
Producer: 20200721
In:
Journal for immunotherapy of cancer vol. 7
Availability: No items available.
|
|
|
939.
|
|
|
|
940.
|
|